What is Stoke Therapeutics, Inc.'s PP&E (net)?

Stoke Therapeutics, Inc. (STOK) reported PP&E (net) of $3.4M in Q1 2026.

How has Stoke Therapeutics, Inc.'s PP&E (net) changed year-over-year?

Stoke Therapeutics, Inc.'s PP&E (net) decreased by 6.0% year-over-year, from $3.61M to $3.4M.

What is the long-term trend for Stoke Therapeutics, Inc.'s PP&E (net)?

Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s PP&E (net) has grown at a 3.3% compound annual growth rate (CAGR), from $2.68M to $3.15M.

What does PP&E (net) mean?

Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Stoke Therapeutics, Inc. STOK PP&E (Net)

PP&E (Net) at other companies

Ionis PharmaceuticalsIONS

$142.4M+38.4%

Jazz PharmaceuticalsJAZZ

$203.1M+13.5%

Xenon PharmaceuticalsXENE

$8.29M-14.5%

Praxis Precision Medicines, Inc.PRAX

$170K-31.2%

Nurix Therapeutics, Inc.NRIX

$21.7M+17.6%

Nuvation BioNUVB

$535K-4.8%

Other financials

Income statement

See full

Revenue$6.2M-96.1%

Operating income-$53.4M-148%

Net income-$50.0M-144%

EPS (diluted)-$0.79-142%

Balance sheet

See full

Cash & equivalents$155.7M-43.4%

Total debt$3.4M-42.5%

Total equity$394.9M+12.8%

Total assets$443.3M+8.9%

Cash flow

See full

Operating cash flow-$60.6M-146%

CapEx$353.0K+132%

Free cash flow-$60.9M-146%

Valuation

See full

Market cap$1.94B+436%

Enterprise value$1.79B+1,855%

P/S60.4×+58.5×

Profitability

See full

Operating margin-577.5%-597pp

Net margin-529.2%-556pp

FCF margin36.2%+18.4pp

Returns & leverage

See full

Return on equity-45.6%-66.1pp

Debt / equity0×0.0×

Current ratio9×+0.6×

Where this comes from

Reported directly by Stoke Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s PP&E (net)?: Stoke Therapeutics, Inc. (STOK) reported PP&E (net) of $3.4M in Q1 2026.
How has Stoke Therapeutics, Inc.'s PP&E (net) changed year-over-year?: Stoke Therapeutics, Inc.'s PP&E (net) decreased by 6.0% year-over-year, from $3.61M to $3.4M.
What is the long-term trend for Stoke Therapeutics, Inc.'s PP&E (net)?: Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s PP&E (net) has grown at a 3.3% compound annual growth rate (CAGR), from $2.68M to $3.15M.
What does PP&E (net) mean?: Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.